InsiderClue
Insiders · Profile

Kemula Pierre Thadee Victor

Chief Financial Officer at Agomab Therapeutics. Filing since 6 Oct 2026. CIK 0002119332

Company
Date
Role
Action
Shares
Amount
Of holding
AGMB Agomab Therapeutics NV
6 Oct 2026
Chief Financial Officer
Bought
10,000
$85.94K
opened
1 decision on file.